NCT03647358 2026-04-14
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
Clinical Trials
12 trialsNCT06941480 2026-04-14
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Memorial Sloan Kettering Cancer Center
Phase 1 Not yet recruiting
NCT06067503 2026-04-13
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Phase 2 Recruiting
NCT07487883 2026-04-02
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
Peking University People's Hospital
Recruiting
NCT07498933 2026-04-01
FAP-targeted PET/NIR in Lung Malignant Tumors
Peking University People's Hospital
Recruiting
NCT05513027 2026-03-23
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection
Washington University School of Medicine
Phase NA Terminated
NCT04143516 2026-03-19
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
Memorial Sloan Kettering Cancer Center
Phase 2/3 Recruiting
NCT06122610 2026-03-19
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
University of Wisconsin, Madison
Phase 1 Recruiting
NCT04668872 2026-03-12
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Memorial Sloan Kettering Cancer Center
Recruiting
NCT07416825 2026-02-18
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
Institute of Oncology Ljubljana
Phase NA Completed
NCT05683964 2026-02-13
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression
Beth Israel Deaconess Medical Center
Phase EARLY_PHASE1 Active not recruiting
NCT04018053 2026-01-27
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Brigham and Women's Hospital
Phase EARLY_PHASE1 Active not recruiting